Klem; Robert E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Klem; Robert E..The latest application filed is for "method for determining recurrence or stable disease after treatment for prostate cancer".

Company Profile

1.8.7

Klem; Robert E. - Rancho Santa Fe CA
Klem; Robert E. - Berkeley Heights NJ
Klem; Robert E. - Florham Park NJ
Klem; Robert E. - San Luis Obispo CA
Klem; Robert E. - Muscatine IA
Klem; Robert E. - Columbia MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method For Determining Recurrence Or Stable Disease After Treatment For Prostate Cancer App 20130323739 - Klem; Robert E. ; et al.	2013-12-05
Method For Determining Likelihood Of Clinical Recurrence Or Clinically Stable Disease Of Prostate Cancer After Radical Prostatectomy App 20120329713 - Klem; Robert E. ; et al.	2012-12-27
Methods for modulating the efficacy of nucleic acid based therapies Grant 7,960,364 - Reardan , et al. June 14, 2	2011-06-14
Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers Grant 7,795,232 - Warrell , et al. September 14, 2	2010-09-14
Methods for Modulating the Efficacy of Nucleic Acid Based Therapies App 20100144840 - Reardan; Dayton T. ; et al.	2010-06-10
Methods for Modulating the Efficacy of Nucleic Acid Based Therapies App 20080167263 - Reardan; Dayton T. ; et al.	2008-07-10
Tri(alkylcarboxylato)gallium (III) products and pharmaceutical compositions containing them Grant 7,119,217 - Jiang , et al. October 10, 2	2006-10-10
Methods and compositions for treating a cell-proliferative disorder using CRE decoy oligomers, BCL-2 antisense oligomers, and hybrid oligomers thereof Grant 7,060,690 - Klem June 13, 2	2006-06-13
Tri(alkylcarboxylato)gallium (III) products and pharmaceutical compositions containing them App 20050261366 - Jiang, Jack B. ; et al.	2005-11-24
Methods and compositions for treating a cell-proliferative disorder using CRE decoy oligomers, BCL-2 antisense oligomers, and hybrid oligomers thereof App 20030176376 - Klem, Robert E.	2003-09-18
Organic polymer reagents for solid phase synthesis of oligonucleotides Grant 5,723,599 - Klem , et al. March 3, 1	1998-03-03
Fluorescent benzothiazole derivatives Grant 5,424,440 - Klem , et al. June 13, 1	1995-06-13
Preparation of filler compositions for paper Grant 4,799,964 - Harvey , et al. January 24, 1	1989-01-24
Process for making quaternary amines of epichlorohydrin Grant 4,066,673 - Doughty , et al. January 3, 1	1978-01-03

Company Registrations

SEC

0001110483

KLEM ROBERT E of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.